March 30, 2026 · Form 4 insider transaction
CAUSEY CHRISTOPHER sold 1,300 shares of United Therapeutics Corporation at $604.64 per share, a transaction worth $786.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.